CNP-106

N/A

Report date: 2025/10/21 14:45:42

Base Information

Drug NameCNP-106
Drug Alias NameCNP-106
ClassificationBiologics
Mechanisms of ActionImmunomodulatorsAcetylcholine receptor; alpha1/beta1/delta/gamma modulators
TargetsAcetylcholine receptor; alpha1/beta1/delta/gamma
Therapy Area/IndicationsMuscle WeaknessMyasthenia Gravis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCour Pharmaceutical Development Company Inc
China Registration ClassN/A

Develop Information

Active CompaniesCour Pharmaceutical Development Company Inc
Inactive CompaniesN/A
Active IndicationsMuscle WeaknessMyasthenia Gravis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A